Business
Christopher Lis, managing director of global healthcare intelligence at J.D. Power, discusses the recent primary care deals by Amazon and CVS Health.
Also, PowerHealth has developed a new automated interface supporting aged care costing studies.
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer's disease.
It also received backing from the founding members of Grab and Zalora.
The acquisition includes Mindstrong's technology assets and some of its employees.
Blood-collection device-maker Vitestro, tech-enabled baby bottle designer Emulait, digital health support platform Reveal HealthTech and AI-based testing platform PocDoc also received funding.
It now plans to release more hypnosis-based DTx apps for anxiety, sleep, and chronic pain.
Maven said the acquisition of Naytal will accelerate its growth in the U.K. and Europe.
The company will use the funds to circulate its ArteraAI Prostate Test and to develop tests to support individualized therapy options for other cancers.
Ida Tin, cofounder and chairwoman at Clue, explains how she sees the fall of Silicon Valley Bank affecting femtech investments and how the sector could progress fruitfully.